VOGT FREDERICK G (Interim CEO & General Counsel) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/3/2026ACC: 0001104659-26-105101
DirectorOfficer· Interim CEO & General Counsel
Since Mar 2026
-17.70K
Net shares
Net seller
$146.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
41.67K acquired · 59.37K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+41.67K
Price / share
—
Trade value
—
% of position
7.4%
9/1/2026
562.49K→604.16K
Common Stock
Direct
Shares
−17.70K
Price / share
$8.28
Trade value
$146.57K
% of position
2.9%
9/1/2026
604.16K→586.46K
Total
Net shares
+23.97K
Net value
-$146.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +41.67K | — | — | 7.4% | 562.49K | 604.16K |
| Common Stock Direct | 9/1/2026 | F · Tax Withholding | −17.70K | $8.28 | $146.57K | 2.9% | 604.16K | 586.46K |
| Total | +23.97K | -$146.57K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common stock
41.67K shares
Shares
−41.67K
Strike price
Held after
83.34K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common stock41.67K shares | 9/1/2026 | M · Option Exercise | −41.67K | — | 83.34K |